newsfilter
← Latest News
PR Newswire·

Acasti Pharma Inc. Announces the Resignation of a Director

LAVAL, QC, March 30, 2023 /PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST) a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing